News

News Releases

Altesa Biosciences To Initiate Clinical Trials Of Promising Antiviral

CEO Giroir announces Altesa’s IND for vapendavir has the FDA green light for clinical study at AdvanSE Conference ATLANTA – May 26, 2022 – Altesa BioSciences, Inc. (Altesa), a clinical-stage biopharmaceutical company developing and commercializing novel antiviral...

Media Coverage

Wall Street Journal

Wall Street Journal

Altesa Bioscience Inc. has raised seed financing to develop drugs for viral diseases.

BioWorld

BioWorld

Hard DRIVE for virus fixes: Altesa, Emory take on global threats.

FIERCE Biotech

FIERCE Biotech

Ex-FDA interim chief Giroir rejoins biotech world with eyes on $50M fundraising for new infectious disease company.